Latest 8-K filings

F&G Annuities & Life disclosed preliminary investment income from alternative investments for Q3 2026, estimating $47M-$57M, which is below their long-term expected return.

Lifevantage Corporation announces a strategic shift of its fiscal year-end from June 30 to December 31, effective September 29, 2026, to better align financial reporting with operational management.

Aethlon Medical, Inc. files an amendment to correct the voting results of Proposal No. 7 from its 2026 Annual Meeting, confirming it was not approved.

Korro Bio has dosed the first cohort of participants in its Phase 1/2 ANCHOR clinical trial for KRRO-121, an RNA-editing oligonucleotide aimed at treating hyperammonemia.

The Campbells Company has successfully priced a $300 million offering of 8.500% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057.

NeoGenomics announces a planned CEO transition with Warren Stone succeeding Tony Zook, alongside preliminary Q3 revenue of $209 million and 28% NGS growth.

AbbVie Inc. announced updated financial guidance for 2026, incorporating $216 million in acquired IPR&D and milestones expense for the third quarter, impacting diluted EPS by $0.11.

Silver Bow Mining Corp. announced the grant of restricted stock units to its CEO, Travis Naugle, as part of its long-term incentive plan.

Serve Robotics Inc. provided an investor presentation detailing significant year-over-year revenue growth, expanded fleet operations across numerous U.S. cities, and strategic advancements in its autonomous delivery ecosystem.

Lucid Group reported Q3 2026 production of 2,954 vehicles and deliveries of 3,806 vehicles, continuing its inventory reduction strategy.

Neostellar Capital Corp. announced preliminary Q3 2026 results, estimating a decrease in Net Asset Value per share and detailing mixed performance across its investment portfolio, including significant unrealized losses.

Valuence Merger Corp. I has extended its deadline to complete an initial business combination by one month, now set for November 3, 2026, and has deposited additional funds into its trust account.

Aimei Health Technology Co., Ltd. has extended its deadline to complete an initial business combination by one month, issuing a promissory note to fund the extension payment.

OFA Group announced the appointment of Eugene M. Johnston as Chief Financial Officer, effective October 1, 2026, following the resignation of Ernest Yeung.

Armada Acquisition Corp. II has amended its Warrant Agreement to align with its IPO prospectus, clarifying warrant exercisability terms.

Endovia Health Sciences announced its investigational drug CannEpil has been determined by the FDA to qualify as a minor use for canine bone cancer pain, paving the way for conditional approval.

Peoples Bancorp Inc. announced a proposed merger with Capital Bancorp, Inc., aiming to enhance scale, diversify earnings, and accelerate strategic growth.

Purple Innovation, Inc. received a notification from Nasdaq regarding its Market Value of Publicly Held Shares falling below the required minimum, triggering a 180-day compliance period.

Lion Copper Corp. announced the appointment of its President and CEO, John Banning, to the Board of Directors, effective September 29, 2026, aligning executive leadership with corporate governance.

MGE Energy and Madison Gas and Electric have amended and restated their credit agreements, extending maturity dates to 2031 and increasing borrowing capacity.

Omnitek Engineering Corp. has sold substantially all assets related to its proprietary diesel engine conversion technology to Omnitek Corp., marking a strategic pivot to the ready-mix business.

SCWorx Corp. announced that the Nasdaq Hearings Panel has granted its request for reconsideration, determining the company has regained compliance with listing requirements and approving continued listing on The Nasdaq Capital Market.

Yunhong Green CTI Ltd. has entered into a Conversion Restriction and Waiver Agreement related to a proposed public offering and has set the date for its 2026 annual shareholder meeting.

Alpha Modus Holdings, Inc. announced the appointment of Atlas Arman and Wenlong Tong to its Board of Directors, with Arman also named Co-Chairman and Tong appointed Co-CEO.

CECO Environmental Corp. announced its decision to voluntarily transfer its primary stock listing from Nasdaq to the Texas Stock Exchange, effective October 19, 2026.

STAAR Surgical announced the appointment of David Bailey, former CEO, as Chief Commercial Officer to drive growth and capitalize on the EVO ICL's market position.

Sabine Royalty Trust announced an increased monthly cash distribution of $0.355450 per unit for October 2026, driven by higher oil and gas production and prices.

Global Asset Management Group, Inc. announced its common stock is now trading on the OTCQB Venture Market and appointed Steven Horne as Chief Growth Officer.

The Kroger Co. has priced a $1.5 billion debt offering consisting of $650 million in 5.800% Senior Notes due 2032 and $850 million in 6.200% Senior Notes due 2036.

CHS Inc. announced the resignation of Board Director Russell Kehl, effective December 2, 2026, with a replacement to be nominated at the upcoming annual meeting.